Dr. Dosier is the lead investigator for SpherIngenics, Inc. and oversaw several Department of Defense contracts for the company. Funding initially focused on stem cell delivery using the alginate microbead system to heal craniofacial cartilage. To accelerate the pathway to market, Dr. Dosier spearheaded a pivot to the use of growth factors and copper oxide to promote wound healing with an emphasis on chronic, ischemic, and infected wounds.

L. Franklin Bost, MBA, IDSA, President and CEO, has more than 30 years of experience in medical product development, marketing and sales, international business, strategic and business planning, and senior management with P&L responsibility. He recently lead the USA and international growth of a biomaterials company which developed, manufactured and marketed bone and cartridge replacement products for reconstruction in over 50 countries.

Barbara D. Boyan, PhD, is a co-inventor of the technology and serves as CSO for SpherIngenics. She has served as Chair of the FDA’s Orthopaedic Device Panel and presently serves on CMS Medical Advisory Board. Boyan has extensive medical device development and commercialization experience; having founded three companies, two of which have been acquired. Dr. Boyan is presently the Dean of Engineering at Virginia Commonwealth University.